4A-5P Analysis
Active Model
Tuberculosis Philippines
Data Source
Updated 2026-02-04
Source NTP-DOH, WHO TB Reports 2024-2025, RITM, PhilHealth
Year
Region
Case
Executive SummaryAvailablenessAdoptionAwarenessAffordabilityConceptualBottleneck MatrixStrategic RecommendationsLeaky BucketConceptualEvidence AuditFact Sheet
AVAIL 40%
ADOPT 37%
AWARE 75%
AFFORD 58%
MIN 37%

Availableness

Physical infrastructure and diagnostic capacity analysis

GeneXpert Diagnostic Network

Formula: Total Facilities x Procedures per Day x Operational Days

ParameterValue
GeneXpert Machines B
1,204
Tests per Machine per Year U
300
Theoretical Capacity (current period, tests/year) B
361,200
Current Utilization Rate D
40%
Actual Tests Performed A
144,480
Unused Capacity (tests/year) A
216,720
Model Notes
  • Unused Capacity (tests/year): ~180K tests/year wasted

Regional Summary Build Up ()

Sorted by primary metric (ascending). Chart omitted — Recharts not available in SvelteKit port.

Config Source screen_to_test_conversiontested_q1_2025
Regional trend chart (placeholder — Recharts removed)
RegionScreen->TestTestedTrace
Region 315.3%33,765primary
Region 616.4%14,096primary
Region 118.2%12,156primary
CALABARZON21.1%47,674primary
Region 1029.5%10,074primary
Region 1145.1%12,466primary
MIMAROPA45.3%10,924primary
Region 747.9%22,590primary
NCR48.7%81,298primary
CAR52.7%6,711primary
Region 1259.4%11,331primary
Region 267.9%15,531primary
NIR101.5%13,651primary
BARMM129.7%7,768primary
Region 13144.6%12,614primary
Region 8246.2%11,659primary
Region 9250.1%10,156primary
Region 5350.5%24,576primary

Regional Screening Performance (Q1 2025)

Q1 2025

Note: legacy manifest field presumptive is proxy-mapped to regional notified_q1_2025 values from the evidence databook.

RegionScreened (CXR)Notified TB CasesNotification RateNotified per 1000 Screenedvs National Notification Rate
Philippines (Total) U
984,973 A
137,425 B
14.0% C
139.5 C
National Benchmark
BARMM U
5,988 A
3,160 B
52.8% C
527.7 C
Above Average
CALABARZON U
226,055 A
21,057 B
9.3% C
93.1 C
Below Average
CAR U
12,729 A
1,416 B
11.1% C
111.2 C
Below Average
MIMAROPA U
24,140 A
4,125 B
17.1% C
170.9 C
Above Average
NCR U
166,793 A
26,656 B
16.0% C
159.8 C
Above Average
NIR U
13,446 A
6,378 B
47.4% C
474.3 C
Above Average
Region 1 U
66,817 A
5,812 B
8.7% C
87.0 C
Below Average
Region 2 U
22,869 A
4,663 B
20.4% C
203.9 C
Above Average
Region 3 U
221,211 A
15,865 B
7.2% C
71.7 C
Below Average
Region 5 U
7,011 A
7,635 B
108.9% C
1089.0 C
Above Average
Region 6 U
85,775 A
6,311 B
7.4% C
73.6 C
Below Average
Region 7 U
47,155 A
7,307 B
15.5% C
155.0 C
Above Average
Region 8 U
4,736 A
4,472 B
94.4% C
944.3 C
Above Average
Region 9 U
4,061 A
3,972 B
97.8% C
978.1 C
Above Average
Region 10 U
34,098 A
4,722 B
13.8% C
138.5 C
Below Average
Region 11 U
27,665 A
5,002 B
18.1% C
180.8 C
Above Average
Region 12 U
19,088 A
5,558 B
29.1% C
291.2 C
Above Average
Region 13 U
8,721 A
3,252 B
37.3% C
372.9 C
Above Average
Data Quality:
APrimary
BProxy
CDerived
DRequired
UUnverifiable

Capacity Funnel

Latest network capacity (2022) + 2024 demand context

Model-defined stage sequence

Capacity Flow
Theoretical Test Capacity361,200 tests/yrActual Tests Performed144,480 tests/yrEstimated Positive Detections57,792 tests/yr
Bottleneck Summary
RankStageValue
PrimaryEstimated Positive Detections57,792 tests/yr
SecondaryActual Tests Performed144,480 tests/yr
Availableness Cascade Checkpoint

Relevant cascade stages for this A dimension

Stage 4
Correct Provider (RHU/Hospital)
315,000
Stage 5
Specimen Collected
220,000 -30.2%
Stage 6
Test Completed (GeneXpert/DSSM)
180,000 -18.2%